Syndax Pharma, Nektar Therapeutics Report Non-Exclusive, Clinical Collab. To Evaluate Safety, Efficacy Of Nektar's NKTR-214 In Combo With Syndax's Entinostat In Patients With Metastatic Melanoma Previously Progressed On Treatment With Anti-PD-1 Agent